Paivi M Lahteenmaki
Overview
Explore the profile of Paivi M Lahteenmaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
570
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taalas T, Oskarsson T, Heyman M, Lund B, Lepik K, Vaitkeviciene G, et al.
Haematologica
. 2025 Feb;
PMID: 39973352
Age and sex have historically been associated with differences in acute lymphoblastic leukemia (ALL) survival. In the NOPHO ALL2008 trial, patients aged 1-45 years with BCR::ABL1-negative B-precursor and Tcell ALL...
2.
Mogensen N, Kreicbergs U, Albertsen B, Lahteenmaki P, Heyman M, Harila A
Hemasphere
. 2024 Jul;
8(7):e124.
PMID: 39006374
This study aimed to assess how parents perceived treatment-related side effects during acute lymphoblastic leukemia (ALL) treatment. Parents of children 1-17.9 years at diagnosis in Sweden, Finland, and Denmark who...
3.
Mogensen N, Kreicbergs U, Albertsen B, Lahteenmaki P, Heyman M, Harila A
Pediatr Blood Cancer
. 2024 Apr;
71(7):e31018.
PMID: 38644601
Background: The improved outcome of childhood acute lymphoblastic leukemia (ALL) over the last decades has increased the importance of assessing late effects and health-related quality of life (HRQoL), particularly when...
4.
Haavisto A, Lampic C, Wettergren L, Lahteenmaki P, Jahnukainen K
Int J Cancer
. 2024 Feb;
154(12):2121-2131.
PMID: 38385825
Childhood cancer survivors are at risk of various endocrine late effects affecting their quality of life. The aim of this study was to assess the prevalence and predictors of endocrine...
5.
Heymer E, Hawkins M, Winter D, Teepen J, Sunguc C, Ronckers C, et al.
Br J Cancer
. 2024 Jan;
130(6):976-986.
PMID: 38243010
Background: Childhood cancer survivors are at risk of subsequent gliomas and meningiomas, but the risks beyond age 40 years are uncertain. We quantified these risks in the largest ever cohort....
6.
Heymer E, Jozwiak K, Kremer L, Winter D, De Vathaire F, Sunguc C, et al.
J Clin Oncol
. 2023 Nov;
42(3):336-347.
PMID: 37972325
Purpose: Childhood cancer survivors are at the risk of developing subsequent colorectal cancers (CRCs), but the absolute risks by treatment modality are uncertain. We quantified the absolute risks by radiotherapy...
7.
Grydeland M, Bratteteig M, Rueegg C, Lie H, Thorsen L, Larsen E, et al.
Pediatrics
. 2023 Aug;
152(3).
PMID: 37646086
Objectives: Physical activity (PA) may modify risks of late effects after cancer. We aimed to examine levels of PA and sedentary time (ST) in a large, international sample of adolescent...
8.
Grahn P, Remes T, Kivisaari R, Suo-Palosaari M, Arikoski P, Koskenkorva P, et al.
BMC Musculoskelet Disord
. 2023 May;
24(1):441.
PMID: 37259117
Background: Childhood brain tumor (BT) survivors have an increased risk of treatment-related late effects, which can reduce health-related quality of life and increase morbidity. This study aimed to investigate lumbar...
9.
Reulen R, Winter D, Diallo I, Veres C, Llanas D, Allodji R, et al.
J Clin Oncol
. 2023 May;
41(21):3735-3746.
PMID: 37235821
Purpose: Radiation to the bone and exposure to alkylating agents increases the risk of bone cancer among survivors of childhood cancer, but there is uncertainty regarding the risks of bone...
10.
Haavisto A, Wettergren L, Lampic C, Lahteenmaki P, Jahnukainen K
Int J Cancer
. 2023 Apr;
153(3):644-653.
PMID: 37078589
Endocrine complications are a common late effect after childhood cancer. Our study assessed the prevalence and predictors of premature ovarian insufficiency (POI) and prospects of pregnancy in young female survivors....